Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Multiple Myeloma”

806 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 806 results

Early research (Phase 1)UnknownNCT04861480
What this trial is testing

Dual-target CAR-T Cells (C-4-29) in the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Chongqing Precision Biotech Co., Ltd 18
Early research (Phase 1)Looking for participantsNCT06270888
What this trial is testing

Hypofractionation (Radiation) Trial for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Chicago 30
Early research (Phase 1)WithdrawnNCT06411301
What this trial is testing

A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors

Who this might be right for
Multiple Myeloma, RefractoryMultiple Myeloma in RelapseMultiple Myeloma Progression
Jules Bordet Institute
Very early researchUnknownNCT04156269
What this trial is testing

BCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
iCell Gene Therapeutics 12
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT00506857
What this trial is testing

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Who this might be right for
Hematologic Malignancies
M.D. Anderson Cancer Center 82
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Large-scale testing (Phase 3)Study completedNCT00049673
What this trial is testing

Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 332
Testing effectiveness (Phase 2)Ended earlyNCT00635024
What this trial is testing

Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 1
Early research (Phase 1)Ended earlyNCT01504490
What this trial is testing

Phase I Study of CS-7017 and Bexarotene

Who this might be right for
Solid TumorsLymphomaMultiple Myeloma
Georgetown University 9
Testing effectiveness (Phase 2)Study completedNCT00040937
What this trial is testing

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 147
Early research (Phase 1)Study completedNCT00258245
What this trial is testing

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 5
Testing effectiveness (Phase 2)UnknownNCT02007811
What this trial is testing

Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more
University of Erlangen-Nürnberg Medical School 15
Testing effectiveness (Phase 2)Study completedNCT00303199
What this trial is testing

Study of ZIO-101 in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Alaunos Therapeutics 35
Testing effectiveness (Phase 2)Looking for participantsNCT05853965
What this trial is testing

Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma

Who this might be right for
Multiple MyelomaMultiple Myeloma in Relapse
Universitätsklinikum Hamburg-Eppendorf 45
Testing effectiveness (Phase 2)Ended earlyNCT00861965
What this trial is testing

Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers

Who this might be right for
Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma
Mirror Biologics, Inc. 2
Early research (Phase 1)Study completedNCT02609230
What this trial is testing

A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma

Who this might be right for
Advanced Solid TumorsMultiple Myeloma
Fox Chase Cancer Center 33
Testing effectiveness (Phase 2)Study completedNCT00469209
What this trial is testing

Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT00017602
What this trial is testing

Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Genta Incorporated
Testing effectiveness (Phase 2)Study completedNCT00514137
What this trial is testing

Sunitinib in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
National Cancer Institute (NCI) 13
Load More Results